BioCentury

BioCentury Grand Rounds Presenter Nominations

Nominate Presenting Companies and Academic Poster Presenters


Grand Rounds U.S. 2026

BioCentury Grand Rounds provides a platform for innovators to connect with BioCentury’s international network of biopharma investors and executives. We invite you to nominate early-stage companies and translational academics to present at the meeting.


While we may not be able to include every suggestion in this meeting, your input is invaluable for broadening our understanding of your ecosystem and areas of expertise.


For each nomination, you will be asked to indicate whether you are willing to make a warm introduction to the nominee. We ask you please wait until the nominee is approved by BioCentury’s Editorial Team before making any introductions. Whether or not a nominee is selected for the program, we welcome them to attend the meeting as a delegate.


Please enter the following information about yourself below, then click Add Nominee to make each individual nomination. Once you have made all of your suggestions, please click Submit All Nominations.


Who is eligible?

Presenting Company — Open to pre-seed, seed, and Series A companies with innovations in disease biology, therapeutic modalities, or enabling tools and technologies for drug and diagnostic development. Benefits include two tickets to attend the event in person, a 10-minute stage slot (8-minute presentation plus 2 minutes for investor questions), access to the partnering platform, and a poster board display.


Academic Poster — Open to translational researchers with a full-time affiliation at an academic or non-profit research institution. Benefits include one ticket to attend the event in person, access to the partnering platform, and a poster board display.


Some very early-stage academic spinouts may fall between these categories. In such cases, please select both options; presenters may then choose the category that best fits.